1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BIOCHIPS MARKET BY TYPE
5.1. Introduction
5.2. DNA Chip
5.3. Protein Chip
5.4. Lab-on-Chip
5.5. Cell-Based and Tissue Chips
6. BIOCHIPS MARKET BY APPLICATION
6.1. Introduction
6.2. Drug Discovery and Development
6.3. Disease Diagnostics
6.4. Genomics
6.5. Proteomics
6.6. Agriculture
6.7. Environmental Testing
6.8. Others
7. BIOCHIPS MARKET BY END-USERS
7.1. Introduction
7.2. Biotech and Pharma
7.3. Hospitals and Diagnostics Centers
7.4. Academic and Research Institutes
7.5. CROs and Government Labs
8. BIOCHIPS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Abbott Laboratories
10.2. Revvity, Inc.
10.3. Standard BioTools Inc
10.4. Randox Laboratories
10.5. Thermo Fisher Scientific
10.6. Bio Rad Laboratories
10.7. Illumina Inc.
10.8. Agilent Technologies
10.9. GE Healthacre
10.10. Cepheid Inc.
10.11. F. Hoffmann-La Roche AG
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations